SOHO 2018 - The 6th Annual Meeting of the Society of Hematologic Oncology
Sep 12 - Sep 15, 2018 | HoustonTXUS
LARVOL is not affiliated with The 6th Annual Meeting of the Society of Hematologic Oncology and all trademarks, logos, and brand names are property of their respective owners
Showing 81 abstracts linked to Trials
FLT3 Inhibitors in AML
Treatment-Free Remission in CML: Selecting the Best Candidates
BCL-2 inhibition in Acute Myeloid Leukemia (AML)
Managing MF Patients After Ruxolitinib Failure
Extended Abstract: Treatment of Lower-Risk Myelodysplastic Syndromes
Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia
Will Mutations Affect Transplant Decisions in Patients with Myelofibrosis?
Extended Abstract: Accelerated Phase Myelofibrosis
First-Line Management of Follicular Lymphoma
Treatment of Newly-Diagnosed Classical Hodgkin Lymphoma
Treatment of Relapsed Hodgkin Lymphoma
Four versus Two Years of Rituximab Maintenance (R-Maintenance) Following Bendamustine Plus Rituximab (B-R): Results of a Prospective, Randomized Multicenter Phase 3 Study in First-Line Follicular Lymphoma (the StiL NHL7-2008 MAINTAIN Study)
Novel CAR T Cells for Multiple Myeloma
Bone Marrow Fibrosis has a Prognostic Role in Adult Patients with Acute Lymphoblastic Leukemia
Obesity and Altered Body Composition in Childhood ALL Survivors